GTB-5550 in Advanced Solid Tumors
GTB-5550 in Advanced Solid Tumors
Recruiting · NCT07541573 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GTB-5550 in Advanced Solid Tumors | Advanced Solid Tumor; Solid Tumor; Tri-specific Killer Engager | Recruiting | Phase 1 | 2026-04-23 | NCT07541573 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GT Biopharma, Inc. | 1 |
| Masonic Cancer Center, University of Minnesota | 48 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Masonic Cancer Center at University of Minnesota | Minneapolis | United States | 12 |